RecruitingNot applicableNCT05979064
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Studying High-grade astrocytoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Northwell Health
- Principal Investigator
- John Boockvar, MD, MDNorthwell Health
- Intervention
- Laparoscopically harvested omental tissue autograft(procedure)
- Enrollment
- 10 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2027
Study locations (1)
- Lenox Hill Brain Tumor Center, New York, New York, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05979064 on ClinicalTrials.govOther trials for High-grade astrocytoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT07551336Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade GliomaBeijing Biotech
- RECRUITINGNCT06214689IDH1 and OCT4 in High Grade AstrocytomaAssiut University
- RECRUITINGPHASE2NCT05683808Venous Thromboembolism Prevention in Outpatients With GliomaUniversity of Vermont Medical Center